Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
82.52
+4.22 (5.39%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Globus Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,101 | 2,939 | 2,519 | 1,568 | 1,023 | 958.1 | |
Revenue Growth (YoY) | 23.49% | 16.65% | 60.62% | 53.35% | 6.76% | 21.43% |
Cost of Revenue | 996.47 | 957.8 | 1,035 | 548.17 | 263.73 | 239.22 |
Gross Profit | 2,104 | 1,981 | 1,484 | 1,020 | 759.12 | 718.88 |
Selling, General & Admin | 1,233 | 1,179 | 981.36 | 643.84 | 432.12 | 408.15 |
Depreciation & Amortization Expenses | 118.92 | 118.19 | 119.37 | 51.03 | 17.74 | 18.53 |
Research & Development | 150.69 | 147.25 | 163.75 | 124.01 | 73.02 | 97.35 |
Other Operating Expenses | 67.91 | 57.38 | 53.4 | 68.27 | 8.3 | 22.91 |
Total Operating Expenses | 1,571 | 1,501 | 1,318 | 887.16 | 531.17 | 546.93 |
Operating Income | 533.2 | 479.82 | 165.99 | 133.14 | 227.95 | 171.95 |
Total Non-Operating Income (Expense) | 125.27 | 125.25 | -45.27 | 32.25 | 15.07 | 8.45 |
Pretax Income | 658.47 | 605.07 | 120.72 | 165.39 | 243.02 | 180.41 |
Provision for Income Taxes | 71.77 | 67.2 | 17.74 | 42.52 | 52.85 | 31.22 |
Net Income | 586.71 | 537.87 | 102.98 | 122.87 | 190.17 | 149.19 |
Net Income to Common | 586.71 | 537.87 | 102.98 | 122.87 | 190.17 | 149.19 |
Net Income Growth | 216.18% | 422.28% | -16.19% | -35.39% | 27.47% | 45.86% |
Shares Outstanding (Basic) | 135 | 135 | 136 | 113 | 100 | 101 |
Shares Outstanding (Diluted) | 137 | 137 | 138 | 115 | 103 | 104 |
Shares Change (YoY) | -1.42% | -0.58% | 20.27% | 11.68% | -0.95% | 1.39% |
EPS (Basic) | 4.35 | 3.98 | 0.76 | 1.09 | 1.89 | 1.48 |
EPS (Diluted) | 4.30 | 3.92 | 0.75 | 1.07 | 1.85 | 1.44 |
EPS Growth | 220.90% | 422.67% | -29.91% | -42.16% | 28.47% | 8.27% |
Free Cash Flow | 610.32 | 588.77 | 405.21 | 165.23 | 104.42 | 219.38 |
Free Cash Flow Growth | 3.66% | 45.30% | 145.25% | 58.23% | -52.40% | 62.34% |
Free Cash Flow Per Share | 4.47 | 4.30 | 2.94 | 1.44 | 1.02 | 2.12 |
Gross Margin | 67.86% | 67.41% | 58.90% | 65.05% | 74.22% | 75.03% |
Operating Margin | 17.20% | 16.33% | 6.59% | 8.49% | 22.29% | 17.95% |
Profit Margin | 18.92% | 18.30% | 4.09% | 7.83% | 18.59% | 15.57% |
FCF Margin | 19.68% | 20.03% | 16.08% | 10.53% | 10.21% | 22.90% |
EBITDA | 814.25 | 756.66 | 419.38 | 278.67 | 296.2 | 241.82 |
EBITDA Margin | 26.26% | 25.75% | 16.65% | 17.77% | 28.96% | 25.24% |
EBIT | 533.2 | 479.82 | 165.99 | 133.14 | 227.95 | 171.95 |
EBIT Margin | 17.20% | 16.33% | 6.59% | 8.49% | 22.29% | 17.95% |
Effective Tax Rate | 10.90% | 11.11% | 14.69% | 25.71% | 21.75% | 17.30% |